News

Congratulations to Professor Beverley Vollenhoven who received an academic promotion last week.…  Read more

Dr Rebecca Lim has been invited to present her work with Business Development Director, Rob Merriel on amniotic exosomes at the prestigious Stanford University BIO SPARK Showcase in San Francisco on 17 October.…  Read more

Hudson Institute of Medical Research is pleased to welcome Dr Joseph (Sefi) Rosenbluh as Director of the new Centre of Functional Genomics within the Centre for Cancer Research.…  Read more

Researchers at Hudson Institute of Medical Research are working to establish and pilot an Australian-first service for analysing the most common type of paediatric solid brain cancer tumour, medulloblastoma, to enable more effective treatment for these paediatric brain cancer patients.…  Read more

Hudson Institute has entered into an international collaborative research agreement with Ariel University (Israel) and ASCI Pharma Pty Ltd on a cancer biology project designed to translate its discoveries into patient treatments.…  Read more

Researchers at Hudson Institute of Medical Research have discovered a crucial genetic marker that heralds better treatment and outcomes for patients with advanced bladder cancer.…  Read more

A new study by Hudson Institute of Medical Research and Fiona Elsey Cancer Research Institute scientists has uncovered important differences between pre- and post- chemotherapy ovarian cancer tumours that may be used to better tackle chemotherapy resistance.…  Read more

A baby’s growth during pregnancy may be dependent on a mother’s levels of a critical nutrient, creatine, according to research from a team of Melbourne researchers.…  Read more

ectopic pregnancy has been named one of the NHMRC’s ‘10 of the Best’ research projects of 2015.…  Read more

Melbourne researchers have identified a protein (follistatin) that could prevent damage to donated organs before and after transplantation, and potentially stop the body rejecting the…  Read more